2021年1月8日全球新冠肺炎(COVID-19)疫情简报,确诊超8844万,致死率仍为2%左右,变异新冠病毒将成2021年新挑战

2021-01-08 MedSci整理 MedSci整理

Worldometers世界实时统计数据显示,截至北京时间2021年1月6日8时11分,全球累计确诊新冠肺炎(COVID-19)病例超过8844万例,新增788,525例,达到88,447,501例,

Worldometers世界实时统计数据显示,截至北京时间2021年1月8日8时11分,全球累计确诊新冠肺炎COVID-19)病例超过8844万例,新增788,525例,达到88,447,501例,累计死亡病例超190万例,达到1,905,073例,新增死亡为14,201例。康复为63,572,085例,重症和危重症病人达到108,190例,全球新冠确诊病例超过100万例的国家达18个,78个国家病例超10万例。美国新冠肺炎累计确诊病例全球最多,超过2210万例,达到22,102,169例,新增244,553例;累计死亡病例超过37.3万例,达到373,711例,新增死亡3721例。昨日报道:2021年1月7日全球新冠肺炎(COVID-19)疫情简报,确诊超8755万,疫苗接种进度缓慢,未能阻止病毒加速传播,疫情控制要到2022年?

全球新冠肺炎致死率仍然有2%左右

梅斯医学通过数据发现,全球新冠肺炎当前死亡率方面,新西兰,印度死亡率最低,低于2%,但印度可能存在过低的统计。美国死亡率略低于2%。而伊朗死亡率超过4%,而也门等不发达国家的致死率超过6%。与此前相比,死亡率在不断下降,一方面可能与医疗治疗水平提升有关,另一方面还可能与病毒变异相关。

中国新增确诊病例53例,其中境外输入病例16例,本土病例37例(河北33例,辽宁2例,北京1例,黑龙江1例)增加无症状感染者57例

根据中国国家卫健委最新通报,1月7日0—24时,31个省(自治区,直辖市)和新疆生产建设兵团报告新增确诊病例53例,其中境外输入病例16例(上海8例,广东3例,辽宁1例,江苏1例,福建1例,河南1例,湖南1例),本土病例37例(河北33例,辽宁2例,北京1例,黑龙江1例);无新增截至1月7日24时,据31个省(自治区,直辖市)和新疆生产建设兵团报告,现有确诊病例521例(其中重症病例13例),逐渐治愈出院病例82176例,逐步死亡病例4634例,累积报告确诊病例87331例,无现有疑似病例。逐步追踪到直接接触者920733人,尚在医学观察的密切接触者23974人。31个省(自治区,直辖市)和新疆生产建设兵团报告补充无症状感染者57例(境外输入18例);当日转为确诊病例5例(境外输入3例);当日解除医学观察17例(境外输入16例);尚在医学观察无症状感染者458例(境外输入243例)。

巴西日新增新冠肺炎确诊病例近9万例 累计死亡超20万例

截至当地时间1月7日,巴西单日新增新冠肺炎确诊病例87843例,累计确诊7961673例,新增死亡病例1524例,累计死亡200498例,累计治愈7096931例。

7日的单日新增确诊病例数量为新冠肺炎疫情在巴西暴发以来的最高值,据当地媒体报道,巴西新冠肺炎死亡人数于当地时间2020年8月8日突破10万人,此后呈下降趋势,全国各州各市开始放松隔离措施并逐渐恢复商业活动,多地的“方舱医院”关停。自2020年11月起,日均新增确诊病例数和死亡病例数再度出现上升,如位于西北部的亚马孙州,过去几天住院治疗的新冠肺炎患者数超过了去年4月及5月登记在院的新冠肺炎患者人数总和,医疗系统濒临崩溃。

南非新冠肺炎单日新增确诊、死亡病例均创新高

南非卫生部7日清晨公布,南非6日新增新冠肺炎确诊21832例、新增死亡病例844例,创下南非自2020年3月5日发现首例新冠肺炎确诊病例以来,单日新增确诊、死亡病例数字新高。

截至目前,南非新冠肺炎累计确诊病例数达到1149591例,累计死亡病例达31368例,均位列非洲地区首位。

去年12月以来,南非新冠肺炎迎来第二波传播高峰期,感染人数大幅激增。此前南非疾控专家指出,第二波疫情较上一波引发的症状更严重、传染人员更广泛,且呈现年轻化趋势。为此,南非总统拉马福萨于2020年12月28日宣布,将针对疫情的“封锁令”重新提升至三级,并加强各项防疫法规的执行力度。

世卫:变异新冠状病毒严重性未增加,或将取代正流行毒株

世界卫生组织欧洲区域办事处主任克卢格表示,世卫组织欧洲区域办事处负责的53个国家中,已有22个国家 发现了变异的新冠状病毒毒株。变异病毒传染性更强,但其引起的位移没有明显变化,这意味着其严重性增加。如果变异毒株的传播性提高,如果不加强控制, 减缓传播速度,病毒将对已经非常紧张且压力重的医疗机构产生严重的影响,变异毒株可能取代当前正在流行的毒株。

世卫专家:变异新冠病毒将成2021年新挑战

根据世界卫生组织的官方通报,截至2021年1月5日,最初在英国检测到的VOC-202012/01新冠病毒变种已在世卫组织六个区域中的五个区域的其他40个国家/地区的少数病例中被发现,而最初在南非发现的501Y.V2变种也在其他6个国家/地区出现

调查和跟踪异常的快速传播事件、意外的疾病表现或重症,加大对变异病毒的系统性测序力度并利用测序数据来推动早期预防,以及更多分享数据。

根据世卫组织欧洲区域办事处数据,欧洲地区目前有超过2.3亿人生活在全国封锁中,还有一些国家将在接下来几周宣布封锁措施。超过四分之一的欧洲国家新冠感染率非常高,卫生医疗系统承受巨大压力。克卢格呼吁各国继续坚持戴口罩、限制社交聚会人数、保持社交距离和洗手,辅以恰当的病毒检测和追踪等防疫措施。

全球多国再度拉响警报,6国出现7种新冠变异病毒

全球超过6个国家再度拉向新冠疫情的警报,这次的传播源头不是英国了,以葡萄牙、尼日利亚以及智利等国家再度出现了7种新冠变异病毒,6个国家7个新冠变异病毒。

这些病毒和早前英国伦敦的变异病毒是完全不同的,其毒株和病毒基因序列似乎变异程度更高,传染性自然也就更强。和此前英国伦敦的变异病毒类似的是,这些病毒本来早就出现了各国之中,而冬季的来临加快了这些病毒的传播速率,这才让各种政府发现和重视。

南非发现的变异新冠病毒或将使疫苗效力减弱

501Y.V2南非突变株与参考基因组Wuh01相比,具有23个核苷酸变异位点,除了与英国突变株B.1.1.7亚型有相同的N501Y突变之外,不同之处在于还包含了对病毒感染能力有潜在重要影响的S蛋白E484K和K417N两个关键位点的突变。而正是较英国突变这一显著不同使得科学家们更关注南非的变异。

E484K的突变改变了受体结合域,后者是新冠病毒S蛋白进入人体的关键部分,也是疫苗诱导中和抗体与病毒结合的重要部位。

西雅图一癌症研究中心的小组评估了从此前感染新冠病毒的患者体内提取中和抗体测试对变异病毒的中和能力,他们发现近期南非和巴西出现的带有E484K位点突变的病毒使中和抗体的作用减弱。该团队的研究1月5日发布,但未经同行评审。

Tulio de Oliveira教授的团队也得出类似的结论,并表示有理由担心中和抗体效力减弱问题。

1月5日,前FDA局长Scott Gottlieb在接受CNBC采访时表示,在南非变异病毒正向其他国家扩散,因此美国民众亟需接种新冠疫苗,“南非新冠病毒变异毒株或将使我们现有的医疗手段失效,尤其是抗体药物。”

洛杉矶每4到5个人中就有1人新冠检测呈阳性

洛杉矶县周三报告补充258例死亡和11841例新病例。 县公共卫生主任芭芭拉·费雷尔(Barbara Ferrer)博士周三说:“今天,我比以往任何时候都更烦恼。” 在夏季,每10人中有1人呈阳性;她说,现在,每4到5个人中就有1人检测呈阳性。 费雷尔在周一的新闻发布会上表示,在洛杉矶县,新冠病毒平均每15分钟就会导致1人死亡。该县公共卫生部门在一份声明中表示,该县周二的新冠肺炎死亡总数超过 1.1万人,其中1000人是在不到一周的夜间死亡的。

上述内容来自海外网,人民网,央视,梅斯医学,卫健委,ourworldindata,worldometers等

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-09-13 axin009
  2. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-28 哈库

    详细的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-09 zb1235672

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-08 W迪迪

    每天都能接收到最新信息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-08 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-08 lovetcm

    #新冠肺炎#新突变减弱疫苗作用?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-08 1472b010m56暂无昵称

    学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-08 飞翔的乌龟

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1941795, encodeId=14321941e95fb, content=<a href='/topic/show?id=aaa686456e2' target=_blank style='color:#2F92EE;'>#致死率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86456, encryptionId=aaa686456e2, topicName=致死率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Mon Sep 13 01:31:19 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920819, encodeId=8b5d920819de, content=详细的, beContent=null, objectType=article, channel=null, level=null, likeNumber=348, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/03/99c5e3417f97c8b9c6cc7e703f31847e.jpg, createdBy=b4702044120, createdName=哈库, createdTime=Thu Jan 28 18:19:13 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342762, encodeId=b1fe1342e62db, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sat Jan 09 23:31:19 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915047, encodeId=c7aa91504ed3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=368, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Sat Jan 09 22:01:12 CST 2021, time=2021-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914631, encodeId=3436914631d9, content=每天都能接收到最新信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e43e5450440, createdName=W迪迪, createdTime=Fri Jan 08 14:00:53 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028966, encodeId=035d1028966f3, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jan 08 11:31:19 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914567, encodeId=634591456eae, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>新突变减弱疫苗作用?, beContent=null, objectType=article, channel=null, level=null, likeNumber=1116, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Jan 08 08:37:48 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914592, encodeId=46b69145921a, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eca5196812, createdName=1472b010m56暂无昵称, createdTime=Fri Jan 08 09:55:01 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914576, encodeId=982b9145e68b, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Jan 08 09:08:59 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914566, encodeId=e61d9145664e, content=<a href='/topic/show?id=148562431a3' target=_blank style='color:#2F92EE;'>#梅斯医学#</a>总能提供一些新的数据!<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>致死率数据,有价值!另外,突变<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>成为今年的关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=176, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62431, encryptionId=148562431a3, topicName=梅斯医学), TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=lifefamily, createdTime=Fri Jan 08 08:33:55 CST 2021, time=2021-01-08, status=1, ipAttribution=)]
    2021-01-08 lifefamily

    #梅斯医学#总能提供一些新的数据!#新冠肺炎#致死率数据,有价值!另外,突变#新冠病毒#成为今年的关键

    0

相关资讯

NEJM:早期高滴度恢复期血浆治疗可降低老年新冠肺炎感染者病情恶化风险

对于新冠肺炎轻症患者,在发病72小时内接受高抗体滴度康复血浆可有效降低老年患者症状恶化风险

2021年1月4日全球新冠肺炎(COVID-19)疫情简报,确诊超8545万,疫苗接种以色列全球领先,13%人口已接种

Worldometers世界实时统计数据显示,截至北京时间2021年1月4日7时11分,全球累计确诊新冠肺炎(COVID-19)病例超过8545万例,新增471,473例,达到85,456,019例,

2021年1月5日全球新冠肺炎(COVID-19)疫情简报,确诊超8599万,中美疫苗接种数量居前

Worldometers世界实时统计数据显示,截至北京时间2021年1月5日7时11分,全球累计确诊新冠肺炎(COVID-19)病例超过8599万例,新增482,087例,达到85,997,633例,

2021年1月7日全球新冠肺炎(COVID-19)疫情简报,确诊超8755万,疫苗接种进度缓慢,未能阻止病毒加速传播,疫情控制要到2022年?

Worldometers世界实时统计数据显示,截至北京时间2021年1月6日7时21分,全球累计确诊新冠肺炎(COVID-19)病例超过8755万例,新增722,425例,达到87,550,092例,

Lancet Diabetes Endo:糖尿病患者感染新冠肺炎后不良预后风险更高

患有糖尿病人群感染新冠肺炎后,死亡及接受重症监护的风险较高,特别是I型糖尿病患者

2021年1月6日全球新冠肺炎(COVID-19)疫情简报,确诊超8580万

Worldometers世界实时统计数据显示,截至北京时间2021年1月5日9时11分,全球累计确诊新冠肺炎(COVID-19)病例超过8580万例,新增671,423例,达到86,807,475例,